Dangerous Drugs
Posted in Dangerous Drugs,Latest News on August 29, 2018
August 28, 2018 – A California federal judge granted final approval to a $17 million settlement in a nationwide class action lawsuit filed by consumers, represented by Daniel Robinson of Robinson Calcagnie, Inc. and Evan Borges of Greenberg Gross LLP, against PHH Corporation, its subsidiaries and affiliates (“PHH”), and Realogy Holdings Corp. and its subsidiaries…
read more
Posted in Dangerous Drugs on April 17, 2014
A study published in April 2014 in the Journal of American Medical Association Internal Medicine (“JAMA”) linked the popular erectile dysfunction drug, Viagra, to an increased risk of melanoma, a deadly form of skin cancer. The study analyzed data from more than 25,000 men who participated in the Health Professionals Follow-up Study and found that…
read more
Posted in Dangerous Drugs on January 30, 2014
According to a recent study published in Psychotherapy and Psychosomatics (1/22/14, “Tripartite Conflicts of Interest and High Stakes Patent Extensions in the DSM-5”, http://www.karger.com/Article/FullText/357499#abstract), panel members for the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) may have financial conflicts of interest (FCOI) due to financial ties with pharmaceutical companies. The…
read more
Posted in Dangerous Drugs on July 17, 2013
According to the Los Angeles Times, generic drugs are the nation’s most commonly used medications. In fact, roughly 80% of prescriptions prescribed by doctors are for generic drugs. Unfortunately for consumers, if a person suffers injury as the result of a defective generic drug, he or she is barred from suing the manufacturer for damages….
read more
Posted in Dangerous Drugs on June 6, 2013
According to The New York Times, an animal study requested by Merck for its type 2 diabetes drug, Januvia, revealed worrisome changes in the pancreases of rats, leading to follow-up studies which now threaten the future of the lucrative diabetes drug, as well as all other drugs in its class.
